Abstract
Biobanks provide a platform for innovative biomedical research of cancer etiology, progression, and prognosis and have improvised translational and personalized medicine to a great extent. They form the cornerstone, providing resources for future investigations and helping us understand the effects of genetic, environmental, and lifestyle factors on human morbidity, mortality, and health. Time 2009 published ten ideas changing the world right now with biobanks providing linkage to clinical, pathologic, and epidemiologic data of emphasizing its role in discovering and developing biomarkers in new therapeutic drugs. In this review, we highlight the emergence of biobanks as definitive platforms for biomarker discovery-based precision oncology as well as its potential to facilitate bench-to-bedside oriented and multiomics-based translational cancer research.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
